° &. Wath Bio-Genes (i) Ltd Lor tone 9@9PL.c072842) November 14", 2016 To. The secretery, The Stock Exchange, Mamba? Thiroze Jeejeebhoy Towers: pare sereet,MOMBAE ~ 400 007 the Secretary, re omel stock Exchange of Indie Leder fachange Plaza, 5th F100Tr Flog Nos G/i, seBrock: Dendra-Kurla Complex, Bandea (8) ,-MONBAT ~ 400 052+ he Secretary: mre Stock Exchange, Annedabedr Kandhenu Complexr Opp : Sahajanand Colleges vee jaepole,anmedabad ~ 360 029 compANY CODE No: 537292 gub: Subutecton of information ike neqalactonsan eile) oF ene SEBI (LORD? Regulations, 2015+ Dear Sir, please find enclosed herewith quarterly Unaudited Resvis’ along with Limited Review Report which is rei Tfied with Statutory Auditor tor the quarter ended September 30°, 2016- the above information is being provided to you under peguiation 33(3)(2) of ne eee (LORD) Regulations, 2015- qnis is for your information end record purpose Thanking You. yours faithfullyr for Nath Bio-Genes (india) Limited, authorised Signatory «aah tone Nath Roa, Arorgeba 43105 7 cou0 297014856 naTH wath Hue gnats cm. vornmnbicdenss - Grow 1 ehatean Winds, 08 Ver Nariman lost Mua * 400020 (MS) Te 022-2287 1001, 2287565345 GOWA Gautam N Associates Chartered Accountants 30, GNA House, Behind ABC Complex, Manmandir Tavels Lane, Adalat Road, Aurangabad 431001 LIMITED REVIEW REPORT To ‘The Board of Directors of NATH BIO-GENES (INDIA) LIMITED. 1. We have reviewed the accompanying statement of unaudited financial results for the quarter ended 30* September 2016 (the Statement) of NATH BIO-GENES (INDIA) LIMITED (the Company) except for the disclosures regarding ‘Public Sharcholding’ and ‘Promoter and Promoters Group Shareholding, which have been traced from the disclosure made by the management and have not been reviewed by us, This statement is the responsibility of the Company's Management and has been approved by the Board of Directors. Our responsibility isto issue a report on the financial statements based on our review. 2. We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the statement is free of material mi-statement. A review is limited primarily to enquities of the company personnel and analytical procedures applied to nancial data and thus provide less assurance than an audit, We have not performed an audit and accordingly, we do not express an audit opinion. 3. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with recognition and measurement principles laid down in Accounting Standard -25 “Interim Financial Reporti specified under the Companies Act, 1956 (which are deemed to be applicable as per Section 133 of the Companies Act, 2013, read with Rule 7 of the Companies (Accounts) Rules, 2014) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of regulation -33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, including ‘the manner in which it isto be disclosed, or that it contains any material mis-statement. For Gautam N Associates Chartered Accountants FRN: 103117W ju E hE | (GautanyNandawat) Partner MN 032742 Place: Aurangabad Dated: 14* November, 2016 eae ceitan kms fot reeien {0N62 KEY £491 SEASON, Weds: Wow pass oO Serta y Sion Mambo 86919760Nach Bio-Genes (8) Led. SSzecnmste oe wee) Petes id Be) es) er) ee Peer | Bae van] Biz) aa] eet (sence Manan a ae) Ang] ah) ea pees = ea] BR) Bal ame Rees ae as| et] 22] cae setetrersownm | ate we] a] aaen| al Hee oh ao) hn] al “ee ere mn | sh Be) BS] akg] as peace 33 | ae| 74a] se Shee 33 ve] ee] Teal "Be 1 Nee ae ae wos] ats] mre] es 1 era 33 mo] Tae] aR) Seema | TS win] wall] mtn] wee aes ham | "88 a) vag] og) Hci 2 ce] 8] alte Sheets wane | et) wa] tte] wth 3 Pslieea ne pa pasesrer st | eose| toro) soo] rane] sina Prenat a | te| ommie| veeuae] aga] Omus| OE era a ee rman] roa] onene| oma] ean] Tae se cecd mo] rma omnes] | ete] cranny ce enn) ve| xa |ge| scm] ected rae |e | | Sart Sat ieee Saal ig] aue] ie] | we] mee icon tevy| sonar] zone] vena] eg] Boe ew anual MG) ME] SA] “ee) Re) ae Ther tact See ganas Ela Talila wae taken on record by the Board of OVers o) Their meeting held on] INOTES : (1 Above Esa) the company dealing in ene maior product eaument () Investor complaints it Nowelance «0, Recelved and Salved - 2, Closing Balance ~ 0 (6) The ‘earlier period figures nave been} Iregrouped | rearrangad where Necessary. peer FOR GAUTAM N ASSOCIATES CHARTERED ACCQUNTANTS: (Partaer)‘Nath Bio-Genes (India) Limited Standalone Statement of Assets and Liabilities FOR GAUTAM N ASSOCIATES: GAUTAN’ as (Partner) ce: Aurangabad IDate : 14th Nov 2016 Rs. In Lacs Particulares [As at 30.09.2016 (Unaudited)] As at 31.03.2016 (Audited) [A_ BQUITIES AND LIABILITIES TT. Sharcholdere Fund (a) Share capital 1600.40] 1600.40] (b) Reserves and Surplus 1235939] 1030.00 Kc) Money received against share warrants 0.00] 0.00] [Sub-total -Shareholders' Fund 13859.70] 12130.40] 2 Share application money pending for allotment 0.00] 0.00] [3 Minotiries Inverest 0.00] 0.00] [4 Non-current liabilities la} Lang Term Borrowings 1500.00 1500.00] b) Deferred Tax Liabilities 00] 0.00] Jc] Other Long Term Liabilities C09} 0.00] le) Long Term Provisions 196.23 17864! [Sub-total - Non-current liabilities 106.23 1678.64 5, Current Liabilities a) Short Term Borrowings 4812.25 4304.48] by Trade Payables 4985.06 4795.13] Je) Other Current Liablitios 1766.95) 3940.21 J) Short Term Provisions 223.56] 21.15| [Sub-total - Current abilities 1785.84] 12860.57| TOTAL. - EQUITY AND LIABILITIES WALT) 26670.01 iB | ASSETS (1) Non Current Assets js) Fixed Awors 27039] B36 [b) Non Current Investments 0.25} 0.26] c) Deferred ‘Tax Assets (Net) 186.85) 85.86) a) Long Term Loane and Advances 1129.98} 1009.51] Je) Other Non Current Assets 0.09] .00| [Sub-total - Non Current Assets 087.43 aa2.99) [@) Current Assets la) Current Investments 499.40] 499.40] b) Inventories 12973,73| 14073.98| 5050.8) 4531.14) J) Cash and Cash Equivalents 66.68} 122.44) J) Shore Term Loans and Advances 4547.01 3184.75 Ip Other Current Assets 107.64| 115.31 [Sub-total - Current Asseis 7325428] 22SI7.02 [TOTAL ASSETS T7SAL.T7| 2667001 0.00 | FOR NATH B10-GENES (NOIA)LTD s\Iu* ‘Sash Kagiwat MANAGNG DIRECTOR 09119604